SK Geo Centric, an arm of SK Innovation, and Plastic Energy, a specialist in plastic pyrolysis, have partnered to construct the Ulsan ARC plastic recycling complex in Ulsan, South Korea. Under the licensing agreement, the pyrolysis plant Ulsan Advanced Recycling Cluster (ARC) will deploy Plastic Energy’s advanced pyrolysis technology and will have an annual capacity […]
QatarEnergy and Chevron Phillips Chemical Company (CPChem) have made the final investment decision to construct the Ras Laffan Petrochemicals Complex, an integrated olefins and polyethylene facility in Ras Laffan Industrial City, Qatar. To this effect, both parties have formed a joint venture, Ras Laffan Petrochemicals, in which QatarEnergy will hold a 70% interest and CPChem […]
Amolyt Pharma, a France-based clinical-stage biotechnology company, has secured €130 million (around $138 million) from a Series C equity financing round led by Sofinnova Partners and co-led by Intermediate Capital Group (ICG). The French biotech company anticipates using the funding to advance its pipeline of therapeutics for rare endocrine and related disorders, including AZP-3601 and […]
StoneBridge Acquisition, an American special purposes acquisition company (SPAC), and DigiAsia Bios, an Indonesian embeddable ‘fintech-as-a-service’ (FaaS) company, have agreed to combine their businesses to form a new entity at a pre-money equity valuation of $500 million. Post-closing, the combined entity will be named DigiAsia and will trade on The Nasdaq Stock Market, with plans […]
Acelyrin has acquired ValenzaBio, a privately held clinical-stage biopharmaceutical company, in an all-stock deal. With the acquisition of ValenzaBio, the US- based late-stage clinical biopharma company, anticipates to add multiple clinical and pre-clinical development programs to its immunology pipeline, including a potentially differentiated therapeutic for the treatment of thyroid eye disease. Acelyrin’s immunology portfolio is […]
Arlington Capital Partners, a US-based private equity firm, has acquired Avian Vaccine Services business from Charles River Laboratories. The terms of the transaction were not disclosed. The new entity dubbed as AVS Bio will operate independently as a standalone platform for Arlington Capital Partners, and serve the biologic manufacturing and bioprocessing markets. AVS Bio offers […]
South Korean internet company Naver has completed the previously announced acquisition of Poshmark, a social e-commerce marketplace, for an enterprise value of around $1.2bn, in a move to create a global player in online fashion re-commerce. The transaction, which was announced in October 2022, is expected to accelerate Naver’s strategy to build a global e-commerce […]
SirionLabs, a Seattle-based artificial intelligence (AI)-powered contract lifecycle management (CLM) platform, has raised its Series D funding to $110 million with a $25 million investment from Brookfield Growth. The fresh funding from Brookfield Growth follows the previously announced $85 million Series D round, which was led by Partners Group with participation from present investors Avatar […]
Dutch automotive manufacturer Stellantis and Archer Aviation have announced a collaboration to produce the latter’s Midnight eVTOL aircraft, an electric vertical take-off and landing (eVTOL) aircraft for use in urban air mobility networks. Being the exclusive contract manufacturer, the Amsterdam-headquartered Stellantis will mass produce Archer Aviation’s eVTOL aircraft and provide up to $150 million in […]
Vivos Therapeutics has secured the US Food and Drug Administration (FDA) 510(k) clearance for its DNA oral device indicated for obstructive sleep apnea (OSA) treatment. The 510(k) approval for the DNA appliance as a Class II device marks the third FDA clearance for Vivos’ oral devices and the first clearance for the medical technology company’s […]